Security key
690469101
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 146,457,154
- Total 13F shares
- 61,768,473
- Share change
- +33,214,060
- Total reported value
- $100,169,419
- Put/Call ratio
- 25%
- Price per share
- $1.63
- Number of holders
- 83
- Value change
- +$54,659,119
- Number of buys
- 44
- Number of sells
- 35
Report period
Q4 2025
Institutions
83
Top holders
10
OVID full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Ovid Therapeutics Inc. SEC filings
Ovid Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 690469101
Recent filing periods:
Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD |
13D/G
3/4/5
13F
|
Takeda Pharmaceutical Company Limited · 10%+ Owner · Company |
12%
|
8,781,996
|
$11,680,055 | $0 | 08 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
|
— |
10%
|
7,114,114
|
$9,461,772 | $0 | 28 Nov 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
9.9%
|
13,259,735
|
$19,889,602 | $0 | 11 Dec 2025 | |
| ADAR1 Capital Management, LLC |
13D/G
13F
|
Company |
6.9%
|
9,284,166
|
$14,111,932 | $0 | 31 Dec 2025 | |
| FEDERATED HERMES, INC. |
13D/G
|
— |
5.9%
|
7,737,166
|
$12,611,581 | $0 | 31 Dec 2025 | |
| Madison Avenue Partners, LP |
13D/G
|
— |
4%
|
2,852,352
|
$969,800 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
1.9%
from 13D/G
|
611,315
|
$794,710 | — | 30 Sep 2025 | |
| Rubric Capital Management LP |
13D/G
|
— |
0.67%
|
478,533
|
$153,131 | $0 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
2,820,813
|
$3,667,058 | — | 30 Sep 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.8%
|
2,650,000
|
$3,445,000 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
2,286,505
|
$2,971,000 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
2,018,024
|
$2,623,431 | — | 30 Sep 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.97%
|
1,427,495
|
$1,855,744 | — | 30 Sep 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.96%
|
1,400,191
|
$1,820,248 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.92%
|
1,350,000
|
$1,755,000 | — | 30 Sep 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.76%
|
1,106,638
|
$1,438,629 | — | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.75%
|
1,095,574
|
$1,424,247 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.67%
|
986,293
|
$1,282,181 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.63%
|
924,576
|
$1,201,949 | — | 30 Sep 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.6%
|
883,154
|
$1,148,098 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.54%
|
783,653
|
$1,018,751 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.5%
|
730,716
|
$949,932 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
648,020
|
$842,631 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.43%
|
625,000
|
$812,500 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.41%
|
596,717
|
$775,732 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.4%
|
589,094
|
$765,822 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
486,877
|
$632,940 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.28%
|
405,382
|
$526,997 | — | 30 Sep 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.26%
|
387,512
|
$503,000 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.25%
|
362,707
|
$471,519 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.23%
|
341,134
|
$443,474 | — | 30 Sep 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.18%
|
265,993
|
$346,000 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.16%
|
238,415
|
$309,939 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
237,979
|
$309,373 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
227,033
|
$295,143 | — | 30 Sep 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.14%
|
202,978
|
$263,871 | — | 30 Sep 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.13%
|
188,295
|
$244,784 | — | 30 Sep 2025 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.13%
|
187,739
|
$244,061 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.13%
|
183,298
|
$238,287 | — | 30 Sep 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.11%
|
160,000
|
$208,000 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.1%
|
151,800
|
$197,340 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.1%
|
151,711
|
$197,224 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
114,923
|
$149,400 | — | 30 Sep 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
95,434
|
$124,064 | — | 30 Sep 2025 | |
| Empowered Funds, LLC |
13F
|
Company |
0.06%
|
91,234
|
$118,604 | — | 30 Sep 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.06%
|
86,652
|
$112,648 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
57,698
|
$75,007 | — | 30 Sep 2025 | |
| Integrated Wealth Concepts LLC |
13F
|
Company |
0.04%
|
52,900
|
$68,770 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0.03%
|
46,987
|
$61,083 | — | 30 Sep 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.03%
|
46,040
|
$59,852 | — | 30 Sep 2025 |
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2025
As of 31 Dec 2025,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,768,473 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Affinity Asset Advisors, LLC, ADAR1 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, FEDERATED HERMES, INC., Point72 Asset Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Saturn V Capital Management LP, and Ally Bridge Group (NY) LLC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
80
Q4 2025 holders
83
Holder diff
3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.